Citation: J. Cupoabbott et al., FOCUS ON QUINUPRISTIN DALFOPRISTIN - AN INVESTIGATIONAL STREPTOGRAMINANTIBIOTIC FOR THE TREATMENT OF MULTIDRUG-RESISTANT GRAM-POSITIVE INFECTIONS/, Formulary (Cleveland, Ohio), 33(9), 1998, pp. 841
Citation: Np. Beckey, DIABETES-MELLITUS THERAPY - EVALUATING THE ROLE OF THE NEWER ANTIDIABETIC AGENTS, Formulary (Cleveland, Ohio), 33(9), 1998, pp. 858
Citation: N. Johnson, MEASURING HEALTH-RELATED QUALITY-OF-LIFE - AN INTRODUCTION TO SURVEY INSTRUMENTS, Formulary (Cleveland, Ohio), 33(9), 1998, pp. 897
Citation: TAXOTERE - INDICATION EXPANDED TO METASTATIC BREAST-CANCER RESISTANT TO ANY CHEMOTHERAPY, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 713-713
Citation: Ac. Scates et Pm. Doraiswamy, FOCUS ON CITALOPRAM - A SELECTIVE SEROTONIN REUPTAKE INHIBITOR FOR THE TREATMENT OF DEPRESSION, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 725
Citation: Le. Ashworth, FOCUS ON RALOXIFENE - A SELECTIVE ESTROGEN-RECEPTOR MODULATOR FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN (VOL 33, PG 305, 1998), Formulary (Cleveland, Ohio), 33(8), 1998, pp. 743-743
Citation: P. Reddy et P. Defusco, THE ROLE OF ANTIESTROGENS IN THE TREATMENT AND PREVENTION OF BREAST-CANCER, Formulary (Cleveland, Ohio), 33(8), 1998, pp. 744